Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for PREVENTION 5 (MELATONIN)

    Client Email Product

    PREVENTION 5 (MELATONIN)

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    13
    US DMFs Filed

    US DMFs Filed

    7
    CEP/COS Certifications

    CEP/COS Certifications

    1
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    6
    API REF. PRICE (USD / KG)
    1,882

    API Market Place

    40
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    4
    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    3
    Uploaded Dossiers

    Uploaded Dossiers

    7
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    4
    EXCIPIENTS
    105
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    14
    REF STANDARD

    EDQM

    0

    USP

    2

    JP

    0

    Other Listed Suppliers

    2
    SERVICES

    0

    Full View ScreenFull Screen View
    Health Canada Issues Recall of Taima Extract's CBD 20mg Melatonin 10mg Capsule
    Health Canada Issues Recall of Taima Extract's CBD 20mg Melatonin 10mg Capsule

    https://recalls-rappels.canada.ca/en/alert-recall/goodnight-dream-caps-unauthorized-product

    HEALTH CANADA
    20 Apr 2023
    Share Share
    RAD Neurim's Melatonin Receives Approval in Europe
    RAD Neurim's Melatonin Receives Approval in Europe

    https://www.ema.europa.eu/en/documents/overview/melatonin-neurim-epar-medicine-overview_en.pdf

    EMA
    25 Nov 2022
    Share Share
    Vestige launches Melatonin oral spray to improve sleep cycle
    Vestige launches Melatonin oral spray to improve sleep cycle

    http://www.pharmabiz.com/NewsDetails.aspx?aid=145368&sid=2

    PHARMABIZ
    21 Jan 2022
    Share Share
    Researchers use 'big data' approach to identify melatonin as possible COVID-19
    Researchers use 'big data' approach to identify melatonin as possible COVID-19

    https://www.sciencedaily.com/releases/2020/11/201109152223.htm

    SCIENCEDAILY
    09 Nov 2020
    Share Share
    COVID-19: Researchers step up with unconventional approaches
    COVID-19: Researchers step up with unconventional approaches

    https://www.fiercebiotech.com/research/melatonin-stem-cells-researchers-step-up-unconventional-approaches-to-covid-19

    Arlene Weintraub FIERCE BIOTECH
    16 Mar 2020
    Share Share
    RAD Neurim Pharma's Slenyto (melatonin) Receives Approval in Europe
    RAD Neurim Pharma's Slenyto (melatonin) Receives Approval in Europe

    https://www.ema.europa.eu/documents/overview/slenyto-epar-medicine-overview_en.pdf

    EMA
    10 Oct 2018
    Share Share
    CHMP recommends paediatric-use marketing authorisation for Kigabeq and Slenyto
    CHMP recommends paediatric-use marketing authorisation for Kigabeq and Slenyto

    http://www.pharmabiz.com/NewsDetails.aspx?aid=110319&sid=2

    PHARMABIZ
    01 Aug 2018
    Share Share
    Two new paediatric-use marketing authorisations recommended by CHMP
    Two new paediatric-use marketing authorisations recommended by CHMP

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/07/news_detail_002998.jsp&mid=WC0b01ac058004d5c1

    EMA
    31 Jul 2018
    Share Share
    Meeting highlights from the CHMP 23-26 July 2018
    Meeting highlights from the CHMP 23-26 July 2018

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/07/news_detail_002994.jsp&mid=WC0b01ac058004d5c1

    EMA
    31 Jul 2018
    Share Share
    Neurim Pharmaceuticals Receives Positive CHMP Opinion for Slenyto
    Neurim Pharmaceuticals Receives Positive CHMP Opinion for Slenyto

    https://www.prnewswire.com/news-releases/neurim-pharmaceuticals-receives-positive-chmp-opinion-for-slenyto-pediatric-prolonged-release-melatonin-for-the-treatment-of-insomnia-in-children-with-autism-spectrum-disorder-asd-300688436.html

    PR NEWSWIRE
    30 Jul 2018
    Share Share
    RAD Neurim Pharms EEC Ltd.'s Slenyto (melatonin) Receives Positive CHMP Opinion in Europe
    RAD Neurim Pharms EEC Ltd.'s Slenyto (melatonin) Receives Positive CHMP Opinion in Europe

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004425/smops/Positive/human_smop_001323.jsp&mid=WC0b01ac058001d127

    EMA
    30 Jul 2018
    Share Share
    Enforcement Report - Week of March 22, 2017
    Enforcement Report - Week of March 22, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf

    FDA
    22 Mar 2017
    Share Share
    Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin
    Neurim Pharmaceuticals Paediatric Prolonged-Release Melatonin

    http://www.prnewswire.com/news-releases/neurim-pharmaceuticals-paediatric-prolonged-release-melatonin-pedprm-to-be-marketed-by-biocodex-in-france-616022474.html

    PR NEWSWIRE
    13 Mar 2017
    Share Share
    Agilis Announces First Patient Treated in Phase IIb Clinical Study
    Agilis Announces First Patient Treated in Phase IIb Clinical Study

    http://www.drug-dev.com/Main/Current-News/Agilis-Biotherapeutics-Announces-First-Patient-Tre-1762.aspx

    DRUG DEVELOPMENT
    21 Nov 2016
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search